Dagmar Kulms

6PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Chemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 14, 2023
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma.

Luise Dunsche, Nikita Ivanisenko, Shamala Riemann

|Jul 26, 2023
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.

Tamara Bintener, Maria Pires Pacheco, Demetra Philippidou

|Jan 13, 2022
Focal adhesion kinase plays a dual role in TRAIL resistance and metastatic outgrowth of malignant melanoma.

Greta Del Mistro, Shamala Riemann, Sebastian Schindler

|Sep 18, 2021
Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers.

Antonella Montinaro, Itziar Areso Zubiaur, Julia Saggau

|Jan 30, 2021
Keratinocytes control skin immune homeostasis through de novo-synthesized glucocorticoids.

Truong San Phan, Leonhard Schink, Jasmin Mann

Pageof 1